MainStreet Investment Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.9% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,659 shares of the healthcare conglomerate’s stock after selling 203 shares during the quarter. MainStreet Investment Advisors LLC’s holdings in UnitedHealth Group were worth $5,392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter valued at $30,000. Finally, AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $30,000. Institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on UNH shares. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Mizuho lifted their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Finally, Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $596.86.
UnitedHealth Group Stock Down 17.8%
UnitedHealth Group stock opened at $311.23 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day moving average price of $482.53 and a two-hundred day moving average price of $519.28. The firm has a market cap of $282.33 billion, a price-to-earnings ratio of 20.08, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a fifty-two week low of $309.10 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business earned $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.70%. UnitedHealth Group’s payout ratio is 35.18%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What is diluted earnings per share (Diluted EPS)?
- Archer Posts Surprise Q1 Beat, Sets Stage for 2025 Revenue Launch
- The 3 Best Fintech Stocks to Buy Now
- Joby Just Flew Two Aircraft at Once—Here’s Why It Matters
- Stock Market Sectors: What Are They and How Many Are There?
- 4 Recent Earnings Winners Riding Fresh Momentum in May
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.